Cardiology – Page 6 – Clinical Trial Results

Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Outcomes After Technology Assisted Nonprescription Rosuvastatin Administration: The TACTiC Trial

April 8, 2024

Disclosures: TBD

Dr. Andre Lamy and Dr. C. Michael Gibson Discuss: Topical Tranexamic Acid To Reduce Seizures In Cardiac Surgery

April 8, 2024

Disclosures: TBD

Dr. Martin Maron and Dr. C. Michael Gibson Discuss: Efficacy And Safety Of Ninerafaxstat, A Novel Cardiac Mitotrope, In Patients With Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results Of IMPROVE-HCM

April 8, 2024

Disclosures: TBD

Dr. James Januzzi and Dr. C. Michael Gibson Discuss: A Selective Aldose Reductase Inhibitor (at-001) For The Treatment Of Diabetic Cardiomyopathy: Primary Results Of The Phase 3 Randomized Controlled Arise-hf Study

April 8, 2024

Disclosures: TBD

Dr. Marianna Fontana and Dr. C. Michael Gibson Discuss: Acoramidis May Improve Cardiac Function and Promote Regression in Transthyretin Amyloid Cardiomyopathy: Data From the ATTRibute-CM Cardiac Magnetic Resonance Substudy

April 7, 2024

Disclosures: TBD

Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: One-month Ticagrelor Monotherapy After Pci In Acute Coronary Syndromes: Principal Results From The Double-blind, Placebo-controlled Ultimate Dapt Trial

April 7, 2024

Disclosures: TBD

Dr. Gervasio Lamas and Dr. C. Michael Gibson Discuss: Effect Of Edetate Disodium Based Chelation Infusions On Cardiovascular Events In Post-MI Patients With Diabetes: The TACT2 Trial

April 7, 2024

Disclosures: TBD

Dr. Howard Herrmann and Dr. C. Michael Gibson Discuss: Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement In Patients With Small Aortic Annuli: Primary Outcomes From The Randomized Smart Trial

April 7, 2024

Disclosures: TBD

Dr. Daniel Gaudet and Dr. C. Michael Gibson Discuss: Plozasiran (ARO-APOC3), An Investigational RNAi Therapeutic, Demonstrates Profound And Durable Reductions In APOC-3 And Triglycerides (TG) In Patients With Severe Hypertriglyceridemia (SHTG), SHASTA-2 Final Results

April 7, 2024

Disclosures: TBD

Dr. Brian Bergmark and Dr. C. Michael Gibson Discuss: Efficacy And Safety Of Olezarsen In Patients With Hypertriglyceridemia And High Cardiovascular Risk: Primary Results Of The BRIDGE-TIMI 73a Trial

April 7, 2024

Disclosures: https://disclosures.acc.org/Public/AnnualMeetingAppConsol?pid=21006